%0 Journal Article
%T Targeted inhibition of histone deacetylase 6 in inflammatory diseases
%A Jie Ran
%A Jun Zhou
%J Archive of "Thoracic Cancer".
%D 2019
%R 10.1111/1759-7714.12974
%X Targeting epigenetic modification of gene expression represents a promising new approach under investigation for the treatment of inflammatory diseases. Accumulating evidence suggests that epigenetic mechanisms, such as histone modification, play a crucial role in a number of inflammatory diseases, including rheumatoid arthritis, asthma, and contact hypersensitivity. Consistent with this role, histone deacetylase (HDAC) inhibitors have shown efficacy in the treatment of inflammatory diseases. In particular, selective inhibitors of HDAC6, a cytoplasmic member of the HDAC family that contains two deacetylase domains, are under investigation as a potential treatment strategy for inflammatory diseases due to their ability to regulate inflammatory cells and cytokines. Here, we review recent findings highlighting the critical roles of HDAC6 in a variety of inflammatory diseases, and discuss the therapeutic potential of HDAC6 inhibitors in these settings
%K Cytokine
%K histone deacetylase
%K histone deacetylase inhibitor
%K inflammatory cell
%K inflammatory disease
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397899/